Literature DB >> 25252801

In response to: safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.

Scott Lucyk1, Benjamin A von Schweinitz, Robert S Hoffman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25252801      PMCID： PMC4252278          DOI： 10.1007/s13181-014-0433-0

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  3 in total

1.  Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.

Authors:  Philip W Moore; J Ward Donovan; Keith K Burkhart; Jeffrey A Waskin; Michelle A Hieger; Audrey R Adkins; Yijin Wert; David A Haggerty; J J Rasimas
Journal:  J Med Toxicol       Date:  2014-06

Review 2.  Benzodiazepine receptor antagonists for hepatic encephalopathy.

Authors:  B Als-Nielsen; L L Gluud; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

3.  Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial.

Authors:  R Saitz; M F Mayo-Smith; M S Roberts; H A Redmond; D R Bernard; D R Calkins
Journal:  JAMA       Date:  1994-08-17       Impact factor: 56.272
  3 in total
  1 in total

1.  Chlordiazepoxide-induced delirium in a patient undergoing alcohol withdrawal: a case report.

Authors:  Melissa A Arabadjief; Omar H Elsayed; Sabina Bashir; Meenakshi R Gundumalla; Derek S Menefee; Cody L Bergman; Nayeem Z Moulana; Rif S El-Mallakh
Journal:  J Med Case Rep       Date:  2022-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.